Toronto, Ontario-Canada. – Following a visit by the College of American Pathologists (CAP), Canada Metabolic Inflammation Diagnostics Inc. (CMID INC.) earned another accreditation based on the biannual on-site inspection. The on-site inspection team included practicing pathology and laboratory medicine professional.
“The CAP’s Laboratory Accreditation Program is widely recognized as the gold standard in lab accreditation,” said Dr. Rafik Ragheb, PhD, CEO and laboratory Director/clinical scientist. “I’m proud of the teamwork shown by the lab to achieve this accreditation.” The United States Federal Government recognizes the CAP Laboratory Accreditation Program, which started in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program. CMID Inc. Laboratory is one of more than 8,000 CAP-accredited facilities worldwide. During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management. “The CMID Laboratory demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Richard M. Scanlan, MD, FCAP, chair of the CAP’s Council on Accreditation. “The CAP congratulates CMID Laboratory on its recent CAP Accreditation.”
To learn more about our laboratory services offered at CMID Please, visit our website www.cmidinc.ca About the College of American Pathologists: As the world’s largest organization of board certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, go to www.cap.org.
CMID INC. is also continuing to pursue Quality Management in Healthcare for ISO 15189 compliance through accreditation Canada Diagnostics (ACD) a Canada-based organization. In addition CMID Inc. is licenced fully under Regular status licence by the Ministry of Health of Ontario- Canada (Laboratory and specimen Collection center licencing Act).
Contact: Dr. Rafik Ragheb, President/ CEO and Director
1.416-332-9444/ +1.647-401-3185
Tool Free: 1.833-332-9444
Dr. Rafik Ragheb addressed the impact of nutrition on the immune system functions and why it is important to test for specific inflammatory markers (Cytokines). This highlights the importance of screening our body's immune response to monitor, intervene and diagnose diseases such as cancer, dementia, diabetes, cardiovascular and lipid disorders.
Copyright © 2024 CMID INC. - All Rights Reserved.
Powered by GoDaddy